Biote Corp. Form 8-K Summary
Business Context and Reporting Period
Biote Corp. filed a Form 8-K dated June 8, 2022, with a signature date of June 9, 2022. The filing furnishes supplemental unaudited quarterly financial results for 2021 of BioTE Holdings, LLC and an investor presentation provided in connection with an investor conference and investor meetings.
The filing identifies Biote Corp.'s Class A common stock and warrants as Nasdaq-listed securities. Biote Corp. qualifies as an emerging growth company.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It states that the 2021 quarterly results are included in Exhibit 99.1 and that the investor presentation is included in Exhibit 99.2, but the exhibit contents are not included in the provided text.
Changes Versus Prior Comparable Period
No quantitative or qualitative comparison is provided in the filing text. The filing references audited financial statements for the years ended December 31, 2021, 2020, and 2019, and unaudited first-quarter financial statements for the three months ended March 31, 2021 and 2022, previously presented in a June 2, 2022 Form 8-K.
Guidance, Outlook, Risks, and Unusual Items
- No specific guidance, outlook, risk update, contingency, or unusual financial item is described in the provided filing text.
- The company states that the investor presentation is summary information and should be considered together with its SEC filings and other public announcements.
- The company undertakes no obligation to update or revise the investor presentation publicly.
- The furnished information is not deemed filed for purposes of Section 18 of the Exchange Act and is generally not incorporated by reference into other SEC filings unless specifically stated.
Investor Verification Items
- Review Exhibit 99.1 for the detailed unaudited quarterly financial results for 2021.
- Review Exhibit 99.2 for management's investor presentation, including any operating outlook or performance commentary.
- Reconcile the supplemental results with the audited 2021 financial statements and the March 31, 2022 financial statements referenced in the filing.
- Confirm the filing's referenced financial metrics, debt and liquidity information, and any guidance against the company's other SEC filings.